Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Arcavi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Harefuah|July 16, 2003
[Drug related taste disturbances: emphasis on the elderly]Lidia Arcavi, Avner Shahar
Archives of Internal Medicine|November 10, 2004
Cigarette smoking and infectionLidia Arcavi, Neal L Benowitz
European Journal of Internal Medicine|June 19, 2007
Symptomatic anemia induced by rosiglitazoneLev Shvidel, Lidia Arcavi, Erica Sigler
American Heart Journal|February 5, 2004
High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) studyLidia Arcavi, Solomon Behar, Avraham Caspi, et al.
Current Drug Safety|April 17, 2010
Appropriate antibiotic prescribing pattern in hospitalized childrenLidia Arcavi, Doaa Okasha, Suzi Trepp, et al.
Plos One|August 14, 2020
Increasing adverse drug reaction reporting-How can we do better?Miri Potlog Shchory, Lee H Goldstein, Lidia Arcavi, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2020
The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reportingMiri Potlog Shchory, Lee Hilery Goldstein, Lidia Arcavi, et al.
Drug Safety|August 13, 2010
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based reviewIlan Youngster, Lidia Arcavi, Renata Schechmaster, et al.
BMJ Open|May 4, 2023
Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDAStephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Harefuah|July 16, 2003
[Drug related taste disturbances: emphasis on the elderly]Lidia Arcavi, Avner Shahar
Archives of Internal Medicine|November 10, 2004
Cigarette smoking and infectionLidia Arcavi, Neal L Benowitz
European Journal of Internal Medicine|June 19, 2007
Symptomatic anemia induced by rosiglitazoneLev Shvidel, Lidia Arcavi, Erica Sigler
American Heart Journal|February 5, 2004
High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) studyLidia Arcavi, Solomon Behar, Avraham Caspi, et al.
Current Drug Safety|April 17, 2010
Appropriate antibiotic prescribing pattern in hospitalized childrenLidia Arcavi, Doaa Okasha, Suzi Trepp, et al.
Plos One|August 14, 2020
Increasing adverse drug reaction reporting-How can we do better?Miri Potlog Shchory, Lee H Goldstein, Lidia Arcavi, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2020
The effect of an intervention program on the knowledge and attitudes among medical staff regarding adverse drug reaction reportingMiri Potlog Shchory, Lee Hilery Goldstein, Lidia Arcavi, et al.
Drug Safety|August 13, 2010
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based reviewIlan Youngster, Lidia Arcavi, Renata Schechmaster, et al.
BMJ Open|May 4, 2023
Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDAStephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, et al.
Pageof 1